Digital vs conventional PET/CT: does the scanner really matter?

Most people never think to ask which scanner their PET/CT will be done on. It is a reasonable assumption that a scan is a scan. It is not quite true, and the gap has widened sharply in the last few years.

Two generations of detector

A PET scanner's job sounds simple: detect the faint flashes of light produced when the tracer in your body decays, and work out where each flash came from. Everything else — resolution, dose, scan time — follows from how well it does that.

Conventional scanners use photomultiplier tubes (PMTs). These are glass vacuum tubes, a technology dating to the middle of the last century. They are large, so several crystals have to share one tube, and the position of a flash has to be estimated by comparing signals across neighbouring tubes. A great deal of information is lost in that estimation.

Digital scanners use silicon photomultipliers (SiPMs). These are solid-state semiconductor devices, small enough that each crystal can have its own detector, and fast enough to count individual photons. There is no estimating and far less loss.

The word "digital" here is not a marketing flourish. It describes a genuine change in how the signal is captured.

What that changes, in four numbers

Spatial resolution — how small a lesion can be seen clearly. A modern digital system such as the uMI Vista resolves to roughly 2.9 mm. A typical analogue scanner sits around 4 to 5 mm. In practice, that is the difference between confidently reporting a 5 mm lymph node and calling it indeterminate.

Time-of-flight resolution — how precisely the origin of each flash is pinned down. Digital: about 300 picoseconds. Conventional: roughly 500 to 550. Better timing means less blur and better contrast, and the benefit is largest in heavier patients, where conventional images tend to go soft.

Sensitivity — how much of the available signal is caught at all. Digital systems capture substantially more. That surplus can be spent on a sharper image, a shorter scan, or a lower injected dose.

Scan time. About 15 minutes for a whole body, against 25 to 30 minutes on a conventional machine. If you have ever tried to lie completely still with bone pain, you will understand why this is not a small thing.

Why it matters more than it sounds

A scan report is not the end product. The treatment decision is.

Cancer staging is a set of thresholds, and thresholds are where resolution counts. Whether a single 6 mm node in the mediastinum is reported as involved can be the difference between a curative operation and a course of chemotherapy first. Whether a solitary bone lesion is seen at all can decide between radical treatment and palliative intent.

The scan is not just a picture. It is the evidence on which the plan is built.

Three situations where the difference is most pronounced:

• Small lesions and early recurrence — precisely the cases where finding disease early still changes the outcome.
• Larger patients, where conventional image quality degrades most.
• Patients who cannot hold still — in pain, breathless, elderly, or children — where halving the acquisition time genuinely rescues a study.

The honest caveats

Two things should be said plainly.

The reporting doctor still matters more than the machine. A superb scanner read by someone without subspecialty oncology training will produce a worse outcome than a modest scanner read by an experienced onco-radiologist. Technology raises the ceiling; it does not replace the reader.

A conventional PET/CT is not a bad scan. Analogue systems have been the backbone of oncologic imaging for two decades and continue to answer most clinical questions perfectly well. The argument is not that conventional scans are useless. It is that when a newer generation is available for the same price, there is no reason to accept less.

The price question

Here is the part that usually surprises people: at Prismaa a digital PET/CT costs the same as a conventional PET/CT elsewhere in Surat.

We were deliberate about that. A newer scanner is a larger capital investment, and the ordinary commercial instinct is to recover it through a premium. We chose to recover it through volume instead, because a technology that only reaches patients who can pay extra is not much of an advance in cancer care.

What to ask, wherever you go

If you are choosing a centre — here or anywhere — these four questions will tell you most of what you need to know:

1. Is the scanner digital (SiPM) or conventional (PMT)? Ask for the model name.
2. Who reports the scan, and what is their training? Sub-specialty onco-radiology or nuclear medicine, or general radiology?
3. Which tracers are available in-house? FDG only, or also gallium-68 studies such as PSMA, DOTA and FAPI?
4. Can I bring my previous scans for comparison, and will they actually be compared? Response assessment is meaningless without it.

Any centre that is proud of its answers will be happy to give them.